HHS vs TECH · rev $185.2M vs P/E 65, rev $1.22B
Harte Hanks Inc (HHS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Harte Hanks Inc (HHS) is a conglomerates company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported HHS revenue for 2024-12-31 was $185.2M. Net income was -$30.3M. Revenue was down 3.3% from 2023-12-31 to 2024-12-31. HHS currently screens at market cap $27.7M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
HHS currently screens at market cap $27.7M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the HHS and TECH stock pages for the full models.
Not investment advice.